Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. - Abraham,E.; Wunderink,R.; Silverman,H. (JAMA, 1995)